跳至主要内容
临床试验/NCT07075159
NCT07075159已完成不适用

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

Janice Hernandez, MD3 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年2月28日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
3
主要终点
Number of participants with wound dehiscence

研究概览

简要总结

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years of age
  • follow-up at specified intervals (1 week/6 week/3 months) in an office setting
  • can give informed consent
  • no patients will be excluded on the basis of gender, ethnicity, or religious background

排除标准

  • Patients <18 years of age or >100
  • allergy to pectin, gelatin, and sodium carboxymethylcellulose
  • adults with impaired consent capacity
  • incarcerated individuals.

研究组 & 干预措施

Wound Dressing

Experimental

At the conclusion of the surgical procedure, patients will receive topical wound dressing to surgical sutured periocular wounds

干预措施: Hydrocolloid Wound Dressing (Device)

Antibiotic Ointment (Control)

No Intervention

At the conclusion of the surgical procedure, patients will receive topical antibiotic ophthalmic ointment to surgical sutured periocular wounds

结局指标

主要结局

Number of participants with wound dehiscence

时间窗: 3 months

YES/NO type question if wound dehiscence is present after removal of the patch

次要结局

  • Patient and Observer Scar Assessment Scale(3 months)

研究者

发起方
Janice Hernandez, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Janice Hernandez, MD

Instructor

University of Kentucky

研究点 (3)

Loading locations...

相似试验